Clinical Management Grant - Request For Proposals

Program Description   The aim of the ALS Association TREAT ALS^TM Clinical Management Grant Program is to improve care and living with ALS with a focus on clinical, psychological and or social management of ALS.

BUDGET: A maximum of $100,000 per year for a maximum of 2 years.

Instructions for on-line submission.

Step 1: Register using this link:    http://alsa.spectrumportal.net/Accounts/Register

Step 2: Login using this link    http://alsa.spectrumportal.net/Accounts/Logon

Step 3: Submit an abstract for an open call using the relevant link.

E-mail researchgrants@alsa-national.org for queries.

APPLICATION RECEIPT DATES:

Letter of Intent: April 21, 2017 Midnight US Eastern Time

Request to submit full application: May 10, 2017

Submission of full application: June 6, 2017 Midnight US Eastern Time

Notification of award: September 1, 2017

Program Description

Examples of relevant clinical management studies for this mechanism include, but are not limited to, the following:

• Studies that address the gaps in the delivery of care (as outlined in the ALS practice parameters)
• Studies that explore and develop telemedicine for the care of individuals with ALS
• Psychological interventions in ALS to address the significant mental health issues facing ALS patients and care givers
• Nutritional and respiratory intervention
• Studies to address the needs of care givers for patients with ALS and cognitive/behavioral impairment
• Development of novel endpoints for clinical trial
• Assistive Technology

Contract Information   This call supports research aimed at improving the lives of people living with ALS and their families. The proposed studies are expected to generate data that can be implemented ALS clinical centres. Applicants must clearly and explicitly articulate what impact the project may have on the quality of life for people with ALS. Clinical trials will not be supported with this funding opportunity.

Funding:

• Maximum $100,000 per year for 2 years
• The maximum allowable direct and indirect cost (maximum of 10% allowed) for the entire period of performance is $200,000

Review Criteria for letter of intent

Scientific Merit: Statistical design will be critically assessed and ability to enrol within the granting period will be critically evaluated.

Relevance to ALS: The impact that the study will have for people with ALS will be evaluated.

Originality of Research: The proposed study will be evaluated in context of current practice and how results may impact a change in practice to benefit people living with ALS and their families.

ALS Association Research Grant Policies and Intellectual Property Policy

Brevity is encouraged for the LOI.

Please be as specific as you can.

The main abstract fields are coded as Long Text Fields.

The fields will automatically format the characters.

Please consider the reviewers’ potential reactions to unnecessary data for an abstract.

Images will not be saved

Using the space bar and return key to format spacing – this will be saved and can also be printed.

Typed names in the signature fields are sufficient for the abstract.

The name of an authorized representative of the Grantee organization should be entered.

An Abbreviated Biosketch or CV should be relevant to the proposal being submitted, not more than two pages of bullet pointed information and include Full Name [first, last], Suffix[es], Title[s], E-mail Address, Significant Relevant Achievements, Contribution to Science, Personal Career Goals, Educational Background, Employment Experience, Position[s] Held, Membership[s], Other Relevant Experience, Selected Relevant Publications, Ongoing Research Support, Past Research Support.

Thank you

Mark Yard | Research

The ALS Association   alsa.org

office 203-641-1158   email mark@alsa-national.org